eXoZymes, Inc. (EXOZ) - Cash Flow Conversion Efficiency
Based on the latest financial reports, eXoZymes, Inc. (EXOZ) has a cash flow conversion efficiency ratio of -0.998x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.52 Million) by net assets ($1.53 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See EXOZ equity to assets ratio to measure how much of total assets are equity-financed.
eXoZymes, Inc. - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how eXoZymes, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check EXOZ cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
eXoZymes, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of eXoZymes, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mirae Asset Global REIT Co. Ltd.
KO:396690
|
-0.005x |
|
Decibel Cannabis Company Inc
V:DB
|
0.028x |
|
Abico FS Co Ltd
TWO:8071
|
0.045x |
|
Vrancart Adjud
RO:VNC
|
N/A |
|
BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877-
F:BLH
|
0.003x |
|
Rosebank Industries PLC
LSE:ROSE
|
0.000x |
|
Surapon Foods Public Company Limited
BK:SSF
|
0.082x |
|
Webstep ASA
OL:WSTEP
|
0.308x |
Annual Cash Flow Conversion Efficiency for eXoZymes, Inc. (2021–2025)
The table below shows the annual cash flow conversion efficiency of eXoZymes, Inc. from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see eXoZymes, Inc. stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.40 Million | $-6.50 Million | -1.914x | -134.48% |
| 2024-12-31 | $10.42 Million | $-8.51 Million | -0.816x | -126.56% |
| 2023-12-31 | $-384.32K | $-1.18 Million | 3.073x | +435.48% |
| 2022-12-31 | $1.37 Million | $-1.26 Million | -0.916x | +30.90% |
| 2021-12-31 | $1.20 Million | $-1.59 Million | -1.325x | -- |
About eXoZymes, Inc.
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.